Drug ID:Drug77
Drug Name:Ferric Gluconate
CID:656646
DrugBank ID:NULL
Modality:Small Molecule
Groups:NULL
US Approved:NULL
Other Approved:NULL
Identifier: NCT04587141
Molecular Formula:C18H33FeO21
Molecular Weight:641.3 g/mol
Isomeric SMILES:C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.[Fe+3]
Synonyms:Ferric gluconate; Ferrulecit; Gluferricon; 38658-53-6; Tris(D-gluconato-O1,O2)iron; C613TM6I6V; iron(III) gluconate; ferric gluconate anhydrous; EINECS 254-064-1; D-Gluconic acid, iron(3+) salt
Phase 0: 0
Phase 1: 0
Phase 2: 0
Phase 3: 0
Phase 4: 0
Description:NULL

Molecular Structure

2D Molecular Structure

Knowledge Graph

dtIDCIDCompound NameGene IDGene NameSpeciesPubMed IDsAction
No data available

  • No data available

Phase Distribution
Phase Description
  • Phase 0: Exploratory trials to assess drug behavior in humans
  • Phase 1: Safety trials to determine safe dosage range
  • Phase 2: Efficacy trials to evaluate therapeutic effects
  • Phase 3: Large-scale trials to confirm efficacy and safety
  • Phase 4: Post-marketing surveillance for long-term safety and efficacy

Trial IDTitlePhaseStatusSponsorIndicationsInterventions
NCT04587141 Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial PHASE3 UNKNOWN Fondazione IRCCS Policlinico San Matteo di Pavia Iron Deficiency Anemia|Inflammatory Bowel Diseases DRUG: Sucrosomial iron|DRUG: Ferric Gluconate|DRU… Details

Disease IDDisease NameDefinitionCategoryRelated DrugsMechanism
No data available

Strategy IDTherapeutic StrategySynonymsRelated DrugsMechanism
No data available

No related literature

You can run management commands to establish drug-literature associations